[Transfusion malaria in promyelocytic leukemia].
Five weeks after re-induction treatment and nine days after discharge from hospital, remittent fever occurred in a 34-year-old woman with promyelocytic leukaemia in full remission. She also had haemolytic anaemia and thrombocytopenia, as well as a reduced creatinine clearance. Findings on physical examination were unremarkable, but Falciparum malaria was found in the blood smear. Infusion of erythrocyte or platelet concentrates, administered in treating the leukaemia, was the probable source of the infection. Ten days after starting the administration of chloroquine and sulfadoxine-pyrimethamine she was discharged from hospital, cured of the malaria.
Shunkert
H
H
Abteilung Innere Medizin II, Rheinisch-Westfälische Technische Hochschule Aachen.
Handt
S
S
de Wit
M
M
Gladziwa
U
U
Glöckner
W M
WM
Sieberth
H G
HG
D000328:Adult; D000818:Animals; D002738:Chloroquine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017707:Erythrocyte Transfusion; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000150:complications* / Q000628:therapy; D008288:Malaria / Q000097:blood / Q000188:drug therapy / Q000635:transmission*; D010963:Plasmodium falciparum; D017713:Platelet Transfusion; D013413:Sulfadoxine / Q000627:therapeutic use; D065227:Transfusion Reaction
D013413:Sulfadoxine; D002738:Chloroquine
Transfusionsmalaria bei Promyelozytenleukämie.